SCHEMBL10338456

SCHEMBL10338456

C1CN(c2nsnc2OC[C@@H]2CO2)CCO1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.58
MAPK1 P28482 3/20 0.58
ALOX15 P16050 2/20 0.58
HSD17B10 Q99714 2/20 0.58
TSHR P16473 2/20 0.58
KMT2A Q03164 4/20 0.57
HTT P42858 3/20 0.56
NPSR1 Q6W5P4 1/20 0.56
HPGD P15428 2/20 0.54
LIPA P38571 3/20 0.50
TDP1 Q9NUW8 2/20 0.49
CYP1A2 P05177 1/20 0.49
ADRB2 P07550 1/20 0.49
ADRB1 P08588 1/20 0.49
CYP3A4 P08684 1/20 0.49
HTR1A P08908 1/20 0.49
CYP2D6 P10635 1/20 0.49
ADRB3 P13945 1/20 0.49
NFKB1 P19838 1/20 0.49
DRD1 P21728 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1588109 1.00 ALDH1A1 (0.58) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL1587116 1.00 ALDH1A1 (0.58) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL11531006 0.82 KMT2A (0.51) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL13953865 0.79 KMT2A (0.69) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL19826849 0.76 KMT2A (0.47) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL11529594 0.75 HTT (0.61) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL30673515 0.73 CYP1A2 (0.67) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL11528671 0.72 TDP1 (0.69) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL10749123 0.71 TDP1 (0.67) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL18908562 0.71 CYP1A2 (0.71) ALDH1A1MAPK1ALOX15HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2073082-A None JP disclosed
US-20210154202-A1 SYNTHESIS OF DENTIMOL, AN ANTIGLAUCOMA DRUG VIRGINIA COMMONWEALTH UNIVERSITY (US) 2021-05-27 US disclosed
WO-2019202519-A1 SYNTHESIS OF DENTIMOL, AN ANTIGLAUCOMA DRUG VIRGINIA COMMONWEALTH UNIVERSITY (US) 2019-10-24 WO disclosed
JP-H0273082-A PRODUCTION OF OPTICALLY ACTIVE (S)-(+)-3-(2,3-EPOXYPROPOXY)-4-MORPHOLINO-1,2,5-THIADIAZOLE YODOGAWA SEIYAKU KK 1990-03-13 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210154202-A1 SYNTHESIS OF DENTIMOL, AN ANTIGLAUCOMA DRUG PTGIR, PTGIS, DNM1L ALDH1A1 2812/4885MAPK1 3820/4885ALOX15 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.